SCHEMBL23522702

SCHEMBL23522702

CCc1cc(C(CC(=O)N(CC)CCO)NC(=O)O)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ HPGD P15428 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 1/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ CYP26A1 O43174 4/20 0.32
▸ LTB4R Q15722 1/20 0.32
▸ LTB4R2 Q9NPC1 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ POLB P06746 1/20 0.31
▸ NPC1 O15118 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19301090 0.86 L3MBTL1 (0.36) L3MBTL1HPGDMEN1KMT2ALMNA
SCHEMBL19283458 0.81 L3MBTL1 (0.42) L3MBTL1HPGDMEN1KMT2ALMNA
SCHEMBL19283532 0.81 L3MBTL1 (0.38) L3MBTL1HPGDALDH1A1NPSR1MAPT
SCHEMBL23522701 0.78 L3MBTL1 (0.44) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL19283511 0.76 LMNA (0.41) L3MBTL1MEN1KMT2ALMNAALDH1A1
SCHEMBL19283648 0.76 L3MBTL1 (0.42) L3MBTL1HPGDMEN1KMT2AALDH1A1
SCHEMBL19301089 0.75 CTSK (0.34) HPGDMEN1KMT2ALMNAALDH1A1
SCHEMBL19283665 0.70 HSP90AA1 (0.38) L3MBTL1HPGDALDH1A1PKMGLA
SCHEMBL19283555 0.69 NPC1 (0.39) L3MBTL1MEN1KMT2ALMNAALDH1A1
SCHEMBL19301144 0.67 FAAH (0.41) L3MBTL1MEN1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210188804-A1 NOVEL POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2021-06-24 — — US disclosed
CN-109153667-B Novel potassium channel inhibitors 阿塞西翁制药公司 2021-04-02 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210188804-A1 NOVEL POTASSIUM CHANNEL INHIBITORS KCNJ2, KCNN2, KCNN1 L3MBTL1 1670/4885HPGD 2251/4885MEN1 1978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback